SKYE
SKYE
NASDAQ · Biotechnology

Skye Bioscience Inc

$1.59
-0.02 (-1.24%)
As of Sep 29, 10:21 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 9 75%
Hold 3 25%
Sell 0 0%
Price Target
Analyst Price Target +900.0% upside
Low Target $11.92
Average Target $15.90
High Target $19.90
Current Price $1.59
Current
$1.59
Target
$15.90
$11.92 $15.90 avg $19.90
Scenario Analysis
Bear Case
$11.92
649.7%
Low target
Base Case
$15.90
+900.0%
Avg target
Bull Case
$19.90
+1,151.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$39.92
-96.0% from high
52-Week Low
$1.50
+6.0% from low
Target vs 52W High
$15.90
-60.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.9%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.8%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -26.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.2%